Opportunity ID: 336746

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AG-22-030
Funding Opportunity Title: Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 29, 2021
Last Updated Date: Nov 29, 2021
Original Closing Date for Applications: Jan 10, 2022
Current Closing Date for Applications: Jan 10, 2022
Archive Date: Feb 15, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
For profit organizations other than small businesses
Small businesses
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Native American tribal governments (Federally recognized)
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites U24 Cooperative Agreement applications aiming to establish misfolded protein polymorphisms resource networks in the area of Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD). The central goal of these resource networks is to standardize and distribute seed, oligomers, and fibrils to other investigators in order to clarify and improve the reproducibility of experiments in AD/ADRD. Establishing standards, understanding the pathological roles of these protein polymorphs, and using newly developed analytic tools to address the direct correlation between patient-to-patient variations in A, ?-synuclein, and tau polymorphs are the long-term goals of the resource networks supported by this FOA.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-030.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or after January 25, 2022 PKG00270658 Dec 10, 2021 Jan 10, 2022 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00270657 Dec 10, 2021 Jan 10, 2022 View

Package 1

Mandatory forms

336746 RR_SF424_5_0-5.0.pdf

336746 PHS398_CoverPageSupplement_5_0-5.0.pdf

336746 RR_OtherProjectInfo_1_4-1.4.pdf

336746 PerformanceSite_4_0-4.0.pdf

336746 RR_KeyPersonExpanded_4_0-4.0.pdf

336746 RR_Budget_3_0-3.0.pdf

336746 PHS398_ResearchPlan_4_0-4.0.pdf

336746 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

336746 RR_SubawardBudget30_3_0-3.0.pdf

336746 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

336746 RR_SF424_2_0-2.0.pdf

336746 PHS398_CoverPageSupplement_5_0-5.0.pdf

336746 RR_OtherProjectInfo_1_4-1.4.pdf

336746 PerformanceSite_2_0-2.0.pdf

336746 RR_KeyPersonExpanded_2_0-2.0.pdf

336746 RR_Budget_1_4-1.4.pdf

336746 PHS398_ResearchPlan_4_0-4.0.pdf

336746 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

336746 RR_SubawardBudget30_1_4-1.4.pdf

336746 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T06:51:02-05:00

Share This Post, Choose Your Platform!

About the Author: